LMNX

Q: What is the price of Luminex (LMNX) today?

The price of Luminex (LMNX) today is $ 36.69, with return of 0% compared to the last year. The price of Luminex (LMNX) started the year trading around $ 0.00 and today it is at $ 36.69. Follow the real-time price chart, the historical price of Luminex (LMNX) and international markets.

Q: When does Luminex (LMNX) pay dividends?

Luminex (LMNX) did not distribute dividends in the last year.

Q: Is Luminex (LMNX) worth it?

Currently, Luminex (LMNX) is priced at $ 36.69, with a P/E of 76.81%, representing a deviation of 7,681% from its historical average P/E. In the last year, the stock showed a variation of 0 in its price and distributed $ 0.00 in dividends, resulting in a Dividend Yield of 0.00%. The total shareholder return was 0.00%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How can I buy Luminex (LMNX) stock?

Investing in stocks of Luminex (LMNX) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much would 100 shares of Luminex (LMNX) yield today?

The yield of Luminex (LMNX) was 19.06% in the last month, 0.00% in the last year and 53.14% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of $ 0.00 in dividends, with a Dividend Yield of 0.00%.If you wanted to buy 100 stocks of Luminex (LMNX) today, the total investment would be $ 3,669.48, based on the current price of $ 36.69.If past performance were to repeat, the return on your investment would be:In 1 year: $ 3,669.48In 5 years: $ 5,619.44In 10 years: $ 6,457.55It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Luminex Corporation

Price

$ 36.69

return (12m)

0.00%

p/e

76.81

p/bv

3.64

DIVIDEND YIELD

0.00%

price LMNX

LMNX

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return of LMNX

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

19.06%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

53.14%

10 years

75.98%

Fundamentals LMNX

review the fundamentals of Luminex shares

P/E

76.81

Sector: -3.74 Industry: -3.74

P/SALES RATIO (PSR)

4.06

Sector: -3.71 Industry: -3.71

P/BV

3.64

Sector: 2.05 Industry: 2.05

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

2.83%

Sector: -63.91% Industry: -63.91%

ROE

4.74%

Sector: -67.36% Industry: -67.36%

ROIC

Sector: -1,129.15% Industry: -1,129.15%

NET MARGIN

5.29%

Sector: -41.63% Industry: -41.63%

GROSS MARGIN

60.31%

Sector: 39.39% Industry: 39.39%

OPERATING MARGIN

12.40%

Sector: -41.51% Industry: -41.51%

P/EBITDA

32.76

Sector: -3.78 Industry: -3.78

P/EBIT

76.05

Sector: -3.91 Industry: -3.91

P/ASSET

2.17

Sector: 1.49 Industry: 1.49

BVPS

10.46

Sector: 1.73 Industry: 1.73

EPS

0.50

Sector: -2.05 Industry: -2.05

EQUITY RATIO

0.60

Sector: 0.41 Industry: 0.41

CAGR REVENUE 5 YEARS

0.95%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

9.24%

Sector: - Industry: -

FAIR VALUE OF Luminex ASSETS ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffet's mentor.

Current price

$ 36.69

Fair Value

$ 0.00

Upside Return potential.

-70.44%

See Graham's ranking

Because it considers equity value in its calculation, the formula does not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals LMNX

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
JNJ	20.28	0.00	0.00%	2.43%	$ 509.48 B	27.26%
PFE	14.95	1.58	10.56%	6.65%	$ 146.96 B	15.65%
ABBV	168.68	-154.98	-91.88%	2.88%	$ 402.80 B	4.00%
NVO	13.80	7.96	57.70%	3.53%	$ 212.69 B	32.78%
MRK	13.09	0.00	0.00%	3.25%	$ 249.10 B	29.63%
AZN	29.65	6.06	20.45%	1.74%	$ 278.65 B	16.17%
BMY	17.58	5.71	32.47%	4.76%	$ 106.18 B	12.57%
GILD	18.45	6.98	37.80%	2.61%	$ 149.66 B	27.88%
ZTS	19.83	9.74	49.11%	1.69%	$ 52.56 B	28.21%
HALO	12.44	14.70	118.17%	0.00%	$ 7.41 B	47.91%
REGN	16.32	2.41	14.79%	0.49%	$ 74.71 B	32.13%
AMGN	24.40	17.77	72.82%	3.00%	$ 170.94 B	19.47%
VRTX	31.73	6.73	21.22%	0.00%	$ 116.60 B	31.35%
MCK	24.84	-173.31	-697.75%	0.37%	$ 100.18 B	1.04%
CAH	29.67	-17.33	-58.40%	1.02%	$ 47.32 B	0.68%
ADMA	22.57	10.96	48.57%	0.00%	$ 4.73 B	42.87%
BIIB	15.91	1.41	8.83%	0.00%	$ 25.59 B	15.98%
HRMY	12.44	2.77	22.24%	0.00%	$ 2.31 B	22.48%

Stock vs Index Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

LMNX Historical Dividends

current DY: 0.00%

5-year average DY: 0.31%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividend	06/17/2021	07/08/2021	0,10000000
Dividend	03/25/2021	04/15/2021	0,10000000
Dividend	12/23/2020	01/14/2021	0,10000000
Dividend	09/24/2020	10/15/2020	0,09000000
Dividend	06/18/2020	07/09/2020	0,09000000
Dividend	03/19/2020	04/09/2020	0,09000000
Dividend	12/19/2019	01/15/2020	0,09000000
Dividend	09/26/2019	10/17/2019	0,09000000
Dividend	06/20/2019	07/11/2019	0,06000000
Dividend	03/21/2019	04/11/2019	0,06000000
Dividend	12/20/2018	01/10/2019	0,06000000
Dividend	09/21/2018	10/12/2018	0,06000000
Dividend	06/22/2018	07/13/2018	0,06000000
Dividend	03/23/2018	04/13/2018	0,06000000
Dividend	12/22/2017	01/12/2018	0,06000000
Dividend	09/22/2017	10/13/2017	0,06000000
Dividend	06/23/2017	07/14/2017	0,06000000
Dividend	03/24/2017	04/14/2017	0,06000000

ABOUT THE COMPANY Luminex

Luminex Corporation

Average user rating I10

4.0 (0 people)

United States

30 years

Founded: 1995

2000

Time since IPO - 25 years

1.325

Employees

The Company Luminex Corporation (United States), is listed on Nasdaq with a market value of $ 1.78 Billion, having an equity of $ 488.05 Millions.

With a total of 1.325 employees, the company is listed in the sector of Health Care and categorized in industry of Biotechnology.

In the last 12 months the Company had a revenue of $ 437.66 Millions, which generated a profit in the amount of $ 23.14 Millions.

As for its main indicators, the Company has a P/E ratio of 76.81, a P/BV ratio of 3.64 and in the last 12 months the Company did not pay dividends.

The Company is traded internationally through the ticker LMNX.

Market cap

$ 1.78 Billion

Net worth

$ 488.05 Millions

US$ 488,047,000.00

Assets

$ 819.03 Millions

US$ 819,031,000.00

Total Shares Outstanding

46.68 Millions

46,675,000

Average Daily Trading Volume

$ -

US$ -

Sector

Health Care

Industry

Biotechnology

LMNX

LMNX revenue and profits

Financial Results LMNX

DRAG THE FRAME TO SEE MORE DATA

LMNX cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

BFRA - Biofrontera

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$ 813.80 41,98% (12M)

P/E

24.84

0.37%

ROE

-697.75%

P/BV

-173.31

CAH - Cardinal Health

$ 198.18 70,66% (12M)

P/E

29.67

1.02%

ROE

-58.40%

P/BV

-17.33

JNJ - Johnson & Johnson

$ 211.58 48,72% (12M)

P/E

20.28

2.43%

ROE

0.00%

P/BV

0.00

MRK - Merck & Co.

$ 100.30 2,85% (12M)

P/E

13.09

3.25%

ROE

0.00%

P/BV

0.00

PFE - Pfizer

$ 25.85 9,78% (12M)

P/E

14.95

6.65%

ROE

10.56%

P/BV

1.58

ABBV - AbbVie

$ 223.32 34,34% (12M)

P/E

168.68

2.88%

ROE

-91.88%

P/BV

-154.98

AZN - AstraZeneca

$ 89.83 37,80% (12M)

P/E

29.65

1.74%

ROE

20.45%

P/BV

6.06

BFRA - Biofrontera

$ - -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$ 813.80 41,98% (12 M)

P/L

24.84

0.37%

ROE

-697.75%

P/VP

-173.31

CAH - Cardinal Health

$ 198.18 70,66% (12 M)

P/L

29.67

1.02%

ROE

-58.40%

P/VP

-17.33

JNJ - Johnson & Johnson

$ 211.58 48,72% (12 M)

P/L

20.28

2.43%

ROE

0.00%

P/VP

0.00

MRK - Merck & Co.

$ 100.30 2,85% (12 M)

P/L

13.09

3.25%

ROE

0.00%

P/VP

0.00

PFE - Pfizer

$ 25.85 9,78% (12 M)

P/L

14.95

6.65%

ROE

10.56%

P/VP

1.58

ABBV - AbbVie

$ 223.32 34,34% (12 M)

P/L

168.68

2.88%

ROE

-91.88%

P/VP

-154.98

AZN - AstraZeneca

$ 89.83 37,80% (12 M)

P/L

29.65

1.74%

ROE

20.45%

P/VP

6.06

Frequently Asked Questions

What is the price of Luminex (LMNX) today?

The price of Luminex (LMNX) today is $ 36.69, with return of 0% compared to the last year. The price of Luminex (LMNX) started the year trading around $ 0.00 and today it is at $ 36.69. Follow the real-time price chart, the historical price of Luminex (LMNX) and international markets.

When does Luminex (LMNX) pay dividends?

Luminex (LMNX) did not distribute dividends in the last year.

Is Luminex (LMNX) worth it?

Currently, Luminex (LMNX) is priced at $ 36.69, with a P/E of 76.81%, representing a deviation of 7,681% from its historical average P/E. In the last year, the stock showed a variation of 0 in its price and distributed $ 0.00 in dividends, resulting in a Dividend Yield of 0.00%. The total shareholder return was 0.00%.

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

How can I buy Luminex (LMNX) stock?

Investing in stocks of Luminex (LMNX) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.

BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

How much would 100 shares of Luminex (LMNX) yield today?

The yield of Luminex (LMNX) was 19.06% in the last month, 0.00% in the last year and 53.14% in the last 5 years (already considering appreciation and dividends).

In the last 12 months, the company paid a total of $ 0.00 in dividends, with a Dividend Yield of 0.00%.

If you wanted to buy 100 stocks of Luminex (LMNX) today, the total investment would be $ 3,669.48, based on the current price of $ 36.69.

If past performance were to repeat, the return on your investment would be:

In 1 year: $ 3,669.48
In 5 years: $ 5,619.44
In 10 years: $ 6,457.55

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

LMNX

Luminex Corporation

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return of LMNX

review the fundamentals of Luminex shares

P/E

P/SALES RATIO (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

P/EBITDA

P/EBIT

P/ASSET

BVPS

EPS

EQUITY RATIO

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

Graham's Fair Value

If you had invested (change) 2 years years ago, ago, you would now have

current DY: 0.00%

5-year average DY: 0.31%

type

Ex - Dividend Date

payment date

value

ABOUT THE COMPANY Luminex

Luminex Corporation

United States

30 years

2000

1.325

PROFIT X PRICE LMNX

Financial Results LMNX

LMNX cash flow

asset growth - LMNX

LMNX balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

PFE - Pfizer

ABBV - AbbVie

AZN - AstraZeneca

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

PFE - Pfizer

ABBV - AbbVie

AZN - AstraZeneca

Frequently Asked Questions